Clinical Trial Update: Study of Panitumumab in the Treatment of Carcinoid Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 study of panitumumab for carcinoid syndrome sponsored by Boston Medical Center has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoid Syndrome

Drugs mentioned

• Panitumumab (panitumumab)

Snippet

Sponsor: Boston Medical Center | Conditions: Carcinoid Syndrome | Phase 2 | Status: WITHDRAWN